Acuity Brands Form 144: 6,000-Share Insider Sale Valued at $1.8 Million

Rhea-AI Filing Summary

Acuity Brands, Inc. (AYI) – Form 144 filing: An unidentified insider has filed a notice of intent to sell 6,000 common shares of Acuity Brands on or about 26-27 June 2025 through Merrill Lynch on the NYSE. The shares were originally acquired on 26 October 2023 via the vesting of a stock award and are valued at approximately $1.81 million, based on the filer’s stated aggregate market value. The proposed sale represents roughly 0.02 % of the 30.6 million shares outstanding, indicating a relatively small, routine disposition. No prior sales were reported over the past three months, and the filer attests to having no undisclosed adverse information under Rule 144. While insider sales can raise sentiment concerns, the limited size versus total float suggests minimal direct impact on share supply or corporate fundamentals.

Positive

• None.

Negative

• Insider disposition: Filing signals the intended sale of $1.81 million in AYI stock, which may be perceived as a minor negative sentiment indicator.

Insights

Securities Analyst

TL;DR: Routine Form 144 for 6,000 AYI shares; small scale, no material impact expected.

This Form 144 discloses a prospective insider sale amounting to about 0.02 % of Acuity Brands’ outstanding shares. The stock was received through normal compensation and is to be sold via Merrill Lynch at an estimated value of $1.81 million. The lack of other recent insider sales and the filer’s affirmative statement under Rule 144 suggest no red-flag information asymmetry. From a portfolio standpoint, such a modest transaction is unlikely to influence liquidity or valuation multiples, though it may be noted by sentiment-focused traders tracking insider activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Road NE STE 1000 Atlanta GA 30326	6000	1806235.00	30644832	06/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/26/2023	Vesting of a Stock Award	ACUITY INC. (DE)			6000	10/26/2023	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Acuity Brands (AYI) shares are being sold under this Form 144?

6,000 common shares are scheduled for sale.

What is the estimated market value of the AYI shares to be sold?

The filer cites an aggregate market value of approximately $1.81 million.

When were the shares acquired and how?

The shares vested on 26 October 2023 from a stock award received as compensation.

What percentage of AYI’s outstanding shares does the sale represent?

Roughly 0.02 % of the 30.6 million shares outstanding.

Which broker will handle the transaction and on which exchange?

The sale will be executed through Merrill Lynch on the NYSE.

Were any AYI shares sold by this insider during the prior three months?

No. The filing states “Nothing to Report” for the past three months.